Can-SOLVE CKD is Canada’s largest-ever kidney research initiative.
Since 2016, our national partnership of patients, scientists, health care professionals, and policy-makers has advanced innovative kidney care solutions to help the millions of Canadians affected by chronic kidney disease (CKD).
This transformative work received a significant boost in 2022 with the announcement of new funding that will support the network over the next five years. Can-SOLVE CKD will receive $3.75 million from the Canadian Institutes of Health Research, matched by more than $8 million raised through the generous support of more than 60 partners.
These funds, exceeding $11.8 million in total, will enable Can-SOLVE CKD to mobilize innovations in diagnosis, treatment and care that will enhance kidney health.